BCM
MRK icon

Brooktree Capital Management’s Merck MRK Stock Holding History

Brooktree Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,398
Closed -$260K – 45
2021
Q4 		$260K Sell
3,398
-48
-1% -$3.82K 0.16% 39
2021
Q3 		$259K Sell
3,446
-1
-0% -$76 0.17% 40
2021
Q2 		$268K Sell
3,447
-165
-5% -$12.3K 0.17% 39
2021
Q1 		$266K Sell
3,612
-2,650
-42% -$195K 0.18% 40
2020
Q4 		$488K Sell
6,262
-242
-4% -$18.5K 0.36% 37
2020
Q3 		$514K Hold
6,504
– – 0.44% 36
2020
Q2 		$479K Hold
6,504
– – 0.45% 35
2020
Q1 		$477K Buy
6,504
+629
+11% +$49.4K 0.55% 35
2019
Q4 		$510K Buy
+5,875
New +$483K 0.47% 41

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Brooktree Capital Management's MRK Position: Q1 2022 in Review

Brooktree Capital Management sold out of Merck (MRK) in Q1 2022, closing a stake of 3,398 shares — an estimated $260K sold.

Brooktree Capital Management first reported a position in MRK in Q4 2019 and held it in 9 quarters. The position peaked at $514K in Q3 2020. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • Brooktree Capital Management reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • Brooktree Capital Management sold 3,398 Merck shares in Q1 2022, an estimated $260K.
  • Brooktree Capital Management first reported a position in Merck in Q4 2019 and held it in 9 quarters.
  • Brooktree Capital Management's Merck position peaked at $514K in Q3 2020.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Brooktree Capital Management's 13F filing for Q1 2022, filed 9 May 2022.